N

NovaBay Pharmaceuticals
D

NBY

0.59000
USD
0.00
(0.46%)
Market Closed
Volume
0
EPS
-1
Div Yield
-
P/E
-0
Market Cap
3,431,560
Related Instruments
ABT
ABT
1.930
(1.47%)
132.820 USD
AZN
AZN
1.940
(2.75%)
72.440 USD
GSK
GSK
-0.120
(-0.31%)
39.070 USD
JNJ
JNJ
1.720
(1.11%)
156.120 USD
MRK
MRK
-0.090
(-0.11%)
83.160 USD
NVS
NVS
3.000
(2.69%)
114.320 USD
PFE
PFE
0.065
(0.27%)
24.185 USD
P
PLX
0.00000
(0.00%)
2.99000 USD
SNY
SNY
1.360
(2.51%)
55.470 USD
More
News

Title: NovaBay Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.